Clinical TrialID 5619
Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
NCT00291785
Colorectal Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5619
- Evidence Id
- 5619
- Core Evidence Id
- 5619
- Source Clinical Trial Id
- 5600
- Herb2 Clinical Trial Id
- HBCT005600
- Nct Id
- NCT00291785
- Title
- Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
- Status
- Completed
- Phase
- Phase 1|Phase 2
- Study Result
- No
- Study Condition
- Colorectal Cancer
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: CT-2106|DRUG: Folinic acid|DRUG: 5-FU (fluorouracil)
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 48
- Outcome Measure
- Phase I: determine the Maximum Tolerated Dose, dose limiting toxicities, safety profile and antitumor activity, Each cycle
- Sponsor Collaborator
- CTI BioPharma
- Funded By
- INDUSTRY
- Location
- Policlinico Universitario "A.Gemelli", Rome, Italy|Istituto Clinico Humanitas, Rozzano, Italy
- Other Id
- CAM201
- Start Date
- 2004-01
- Primary Completion Date
- 2007-08
- Completion Date
- 2008-09
- First Posted
- 2006-02-15
- Results First Posted
- Last Update Posted
- 2011-06-08
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00291785
- Title Cn
- Title En
- Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
- Bilingual Status
- semi_complete